Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.

Erfani E, Roudi R, Rakhshan A, Sabet MN, Shariftabrizi A, Madjd Z.

Int J Biol Markers. 2016 Feb 29;31(1):e53-61. doi: 10.5301/jbm.5000165.

PMID:
26391478
2.

Comparative gene-expression profiling of CD133(+) and CD133(-) D10 melanoma cells.

Roudi R, Ebrahimi M, Sabet MN, Najafi A, Nourani MR, Fomeshi MR, Samadikuchaksaraei A, Shariftabrizi A, Madjd Z.

Future Oncol. 2015;11(17):2383-93. doi: 10.2217/fon.15.174. Epub 2015 Aug 19.

PMID:
26285774
3.

Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.

Sabet MN, Rakhshan A, Erfani E, Madjd Z.

Asian Pac J Cancer Prev. 2014;15(19):8161-9.

4.

Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer.

Roudi R, Madjd Z, Korourian A, Mehrazma M, Molanae S, Sabet MN, Shariftabrizi A.

Cancer Biomark. 2014;14(6):457-67. doi: 10.3233/CBM-140424.

PMID:
25335738

Supplemental Content

Loading ...
Support Center